Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study

被引：0
|
作者：
Junji Tsurutani
Yukinori Sakata
Toshiyuki Matsuoka
机构：
[1] Kindai University Faculty of Medicine,Department of Medical Oncology
[2] Showa University,Advanced Cancer Translational Research Institute
[3] Eisai Co.,Clinical Planning and Development Department
[4] Ltd.,undefined
来源：
Breast Cancer | 2019年 / 26卷
关键词：
Eribulin; Chemotherapy-induced peripheral neuropathy; Risk factors; Post-marketing study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：235 / 243
页数：8
相关论文
共 50 条
  • [41] Implementation of personalized multidisciplinary neuropathy management program for chemotherapy-induced peripheral neuropathy symptoms in breast cancer patients
    Huo, Hongbo
    Zhou, Shaoguang
    Xue, Yanyan
    Mu, Xinxin
    Du, Na
    Cao, Zhongru
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024,
  • [42] Safety and efficacy of cryotherapy in the prevention and treatment of chemotherapy-induced peripheral neuropathy in breast cancer patients
    Costa, Rafael B.
    Nogueira-Rodrigues, Angelica
    Bessa, Claynner Paccely Oliveira
    Menezes, Rafaela Cristina Adalberto
    Oliveira, Fernanda Coelho de Miranda Jorge
    Silva, Matheus Costa E.
    Paes, Flavia Rocha
    Ferrari, Bruno L.
    CANCER RESEARCH, 2023, 83 (05)
  • [43] Balance Impairment Is Associated With Neuromuscular Dysfunction In Breast Cancer Patients With Chemotherapy-induced Peripheral Neuropathy
    Ritzmann, Ramona
    Kneis, Sarah
    Wehrle, Anja
    Freyler, Kathrin
    Lehmann, Katrin
    Rudolphi, Britta
    Bartsch, Hans Helge
    Bertz, Hartmut
    Hildenbrand, Bernd
    Gollhofer, Albert
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2015, 47 (05): : 691 - 691
  • [44] Effect of gradient pressure therapy on the prevention of chemotherapy-induced peripheral neuropathy in patients with breast cancer
    Guo, Dongxue
    Zhao, Fangfei
    Li, Ran
    Zhou, Lizhi
    SUPPORTIVE CARE IN CANCER, 2024, 32 (06)
  • [45] INCIDENCE OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS IN CLINICAL PRACTICE
    Mazilu, Laura
    Stanculeanu, Dana-Lucia
    Gheorghe, Andreea-Daniela
    Voinea, Felix
    Suceveanu, Adrian-Paul
    Pituru, Silviu
    Diaconu, Camelia Cristina
    Parepa, Irinel-Raluca
    Stoian, Anca Pantea
    Pop, Corina Silvia
    Suceveanu, Andra-Iulia
    FARMACIA, 2019, 67 (03) : 472 - 476
  • [46] A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan
    Yucherng Chen
    Taeko Katayose
    Soshi Nagaoka
    Yongzhe Piao
    Kensei Yamaguchi
    Hiroya Asou
    Gastric Cancer, 2021, 24 : 1320 - 1329
  • [47] A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan
    Chen, Yucherng
    Katayose, Taeko
    Nagaoka, Soshi
    Piao, Yongzhe
    Yamaguchi, Kensei
    Asou, Hiroya
    GASTRIC CANCER, 2021, 24 (06) : 1320 - 1329
  • [48] Molecular subtypes might affect chemotherapy-induced peripheral neuropathy in breast cancer patients receiving neoadjuvant chemotherapy
    Altundag, Kadri
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2018, 110 : 11 - 11
  • [49] Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer
    Sugimoto, Mitsuru
    Takagi, Tadayuki
    Suzuki, Rei
    Konno, Naoki
    Asama, Hiroyuki
    Sato, Yuki
    Irie, Hiroki
    Okubo, Yoshinori
    Nakamura, Jun
    Takasumi, Mika
    Hashimoto, Minami
    Kato, Tsunetaka
    Kobashi, Ryoichiro
    Hikichi, Takuto
    Ohira, Hiromasa
    FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2022, 68 (01) : 1 - 10
  • [50] IMPACT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY ON THE QUALITY OF LIFE IN CANCER PATIENTS
    Novak, Marica
    Milicevic, Jasminka
    Bisof, Vesna
    ACTA CLINICA CROATICA, 2022, 61 (01) : 52 - 61
12345